Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Claro Scientific is a private U.S. diagnostics and biotechnology company developing SpectraWave, a reagentless diagnostic and analytical platform based on patented multidimensional optical profiling. Its associated SpectraNet software and database system is designed to interpret optical signatures and rapidly characterize biologic and non-biologic samples in under five minutes. The company appears to focus on platform applications rather than a traditional therapeutic drug pipeline, with use cases spanning medical diagnostics, protein characterization, cellular analysis, biotechnology process development, personalized health monitoring, blood banking, biodefense, food safety, veterinary medicine, and environmental monitoring. Claro Scientific is headquartered in St. Petersburg, Florida and remains an active private company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Claro Scientific.